AbbVie (ABBV) Return on Assets [ROA] (2013 - 2026)
AbbVie (ABBV) posted Return on Assets [ROA] of 7.32% for Q3 2026, up 5.55 percentage points from 1.77% a year earlier and up 2.67 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Return on Assets [ROA] (2013 - 2026) Analysis & Trends
For FY2025, AbbVie's Return on Assets [ROA] came in at 3.15%, down 0.03 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for three consecutive years, with a five-year change of -0.71 percentage points (FY2020 to FY2025).
- In prior years, AbbVie's Return on Assets [ROA] was 3.18% in FY2024 (-0.39 pp), 3.56% in FY2023 (-4.74 pp), 8.30% in FY2022 (+0.53 pp) and 7.77% in FY2021 (+3.92 pp).
- The Q3 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q4 2022.
- On a year-over-year basis, Return on Assets [ROA] increased in three of the last eight quarters, with an average year-over-year change of +0.34 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2026, with a gain of 5.55 percentage points; the weakest was Q4 2023, with a drop of 4.86 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 4.65% (Q2 2026), 2.69% (Q1 2026) and 3.16% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 13.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.32% |
| Jun 30, 2026 | 4.65% |
| Mar 31, 2026 | 2.69% |
| Dec 31, 2025 | 3.16% |
| Sep 30, 2025 | 1.77% |
| Jun 30, 2025 | 2.76% |
| Mar 31, 2025 | 3.10% |
| Dec 31, 2024 | 3.08% |
| Sep 30, 2024 | 3.60% |
| Jun 30, 2024 | 3.68% |
| Mar 31, 2024 | 4.23% |
| Dec 31, 2023 | 3.60% |
| Sep 30, 2023 | 4.80% |
| Jun 30, 2023 | 6.44% |
| Mar 31, 2023 | 5.56% |
| Dec 31, 2022 | 8.46% |
| Sep 30, 2022 | 9.43% |
| Jun 30, 2022 | 8.83% |
| Mar 31, 2022 | 8.62% |
| Dec 31, 2021 | 7.82% |
API Access
AbbVie Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();